Early-Onset Toxicities from 5-FU and Capecitabine

Samuel J. Klempner, MD, provides insight on defining early-onset toxicities from 5-FU and capecitabine in patients with colorectal cancer, including the frequency, the signs to recognize, and when to resume chemotherapy.

[@aremedyproject9569]

Patients aren’t told what’s outside of what they’re told so they often keep those to themselves thinking it’s not related or not important because no doctor mentioned what’s rare or the definition of what’s severe. Cancer’s severe so patients keep negative effects of treatment to themselves.

[@extremereclusefallows5779]

Where do they dream up these drug names. More of that horror movie Frankenstein.

[@1pfennig]

Is this for skin cancer, that is what I used for 4 weeks 2X a day

[@rickelleruby7491]

What is this used for? Triple negative breast cancer?

[@thelonelyboner1]

Cool